Home / Blog / Product Liability / Baxter recalls intravenous solutions due to particulate matter

Baxter recalls intravenous solutions due to particulate matter

Posted on July 19, 2015 1:27 pm under Product Liability

Two lots of intravenous solutions are being recalled by Baxter International Inc. after it was learned that the products may contain particulate matter, which would create serious health risks among users, the U.S. Food and Drug Administration (FDA) reported on July 17.

Two products are affected by the recall: 0.9% Sodium Chloride Injection, USP, 50 mL VIAFLEX Plastic Container with Product Code 2B1301, Lot Number P319921, Expiration Date of 12/31/2015, and NDC 0338-0049-11; and 0.9 % Sodium Chloride Injection, USP, 100 mL MINI-BAG Plus Container with Product Code 2B0043, Lot Number P327635, Expiration Date of 12/30/2015, and NDC 0338-0553-18.

The company received one customer complaint about the presence of particulate matter. The particulate matter was identified to be an insect.

Injecting an IV solution contaminated with particulate matter poses serious health risks, including blood clots, organ damage, or sometimes even death. To learn more about taking legal action after being harmed by a defective medical product in Milwaukee, speak with an attorney at Habush Habush & Rottier S.C. ® by calling (414) 271-0900 today.